Advancing Oncology Research and Minimal Residual Disease Detection with Inocras’s Whole Genome Cancer Platform
Join us for an engaging presentation with our Chief Medical Officer, Erin Connolly-Strong, PhD, followed by a head-to-head comparison of targeted panel sequencing (TPS) and our whole genome CancerVision test by Weill Cornell Medicine Senior Research Fellow, Majd Al Assad, MD.
We’ll conclude with an interactive fireside chat between our co-founder, YoungSeok Ju, and Ultima Genomics VP of Applications, Ariel Jaimovich, as they explore the synergy between Inocras’s whole genome-based, tumor-informed MRDVision and Ultima Genomics’ ppmSeqâ„¢ technology.
Tuesday, April 29th
3:00 – 4:00 PM
Spotlight Theater B